Long-term catheterization inevitably leads to a catheterassociated bacteriuria caused by multispecies bacterial biofilms growing on and in the catheters. The overall goal of the presented study was (1) to unravel bacterial community structure and function of such a uropathogenic biofilm and (2) to elucidate the interplay between bacterial virulence and the human immune system within the urine. To this end, a metaproteomics approach combined with in vitro proteomics analyses was employed to investigate both, the pro-and eukaryotic protein inventory. Our proteome analyses demonstrated that the biofilm of the investigated catheter is dominated by three bacterial species, that is, Pseudomonas aeruginosa, Morganella morganii, and Bacteroides sp., and identified iron limitation as one of the major challenges in the bladder environment. In vitro proteome analysis of P. aeruginosa and M. morganii isolated from the biofilm revealed that these opportunistic pathogens are able to overcome iron restriction via the production of siderophores and high expression of corresponding receptors. Notably, a comparison of in vivo and in vitro protein profiles of P. aeruginosa and M. morganii also indicated that the bacteria employ different strategies to adapt to the urinary tract. Although P. aeruginosa seems to express secreted and surfaceexposed proteases to escape the human innate immune system and metabolizes amino acids, M. morganii is able to take up sugars and to degrade urea. Most interestingly, a comparison of urine protein profiles of three long-term catheterized patients and three healthy control persons demonstrated the elevated level of proteins associated with neutrophils, macrophages, and the complement system in the patient's urine, which might point to a specific activation of the innate immune system in response to biofilm-associated urinary tract infections. We thus hypothesize that the often asymptomatic nature of catheter-associated urinary tract infections might be based on a fine-tuned balance between the expression of bacterial virulence factors and the human immune system. Molecular & Cellular Proteomics 14: 10.1074/mcp.M114.043463, 989-1008, 2015.Catheter-associated urinary tract infections (CAUTIs) 1 account for up to 40% of all nosocomial infections and are thus the most prevalent source of hospital-acquired infectious diseases (1, 2). CAUTIs are mostly "asymptomatic" and characterized by less than 10 5 colony-forming units per milliliter urine, which do not cause any signs of infection or symptoms. A symptomatic CAUTI, usually correlated to a number of colony-forming units (CFUs) exceeding the above mentioned threshold, is diagnosed when symptoms commonly associated with urinary tract infections (e.g. fever, dysuria, urgency, flank pain, or leukocytosis) occur (3). The risk that CAUTIs become symptomatic increases dramatically during catheterFrom the ‡Institute